MRC1 and neoplasm: With the increasing utilization of somatic gene testing and immunohistochemistry (IHC) for cancer patients suspected of LS, a subset of patients with microsatellite instability (MSI) or loss of MMR protein expression by IHC in the tumor tissue but without germline MMR pathogenic variants could be identified.